Researchers have revealed a new method to significantly enhance the efficacy of bispecific antibody therapies in treating solid tumors. Their findings were published on May 13 in Cell Reports Medicine.
May 31, 2024
0
21
A research group centered at the University of California San Diego School of Medicine has drilled deep into a dataset of over 3 million individuals compiled by the direct-to-consumer genetics company 23andMe, Inc., and found ...
Apr 5, 2024
0
60
Researchers have developed a revolutionary biosensor using terahertz (THz) waves that can detect skin cancer with exceptional sensitivity, potentially paving the way for earlier and easier diagnoses. Published in IEEE Transactions ...
Feb 20, 2024
0
46
A study led by the Peter Doherty Institute for Infection and Immunity (Doherty Institute) has found that CD4+ T cells, traditionally called 'helper T cells' for their role in aiding the activation of other immune cells, are ...
Jan 19, 2024
0
49
Prostate cancer is the most common cancer in men other than skin cancer, and more than 288,000 new cases are diagnosed every year, according to the American Cancer Society. The disease's fatality rate has decreased by more ...
Dec 21, 2023
0
11
Artificial intelligence (AI) is already widely used in medical diagnostics. An Austrian-Australian research team led by dermatologist Harald Kittler from MedUni Vienna has investigated the extent to which diagnosis and therapy ...
Oct 23, 2023
0
57
Researchers from QIMR Berghofer have uncovered compelling new evidence that establishes why people with hair loss can be more susceptible to deadly skin cancers.
Oct 3, 2023
0
40
Artificial intelligence (AI) is already being used to diagnose skin cancer, but it cannot (yet) keep pace with the complex decision-making of doctors in practice. An international research team led by Harald Kittler of MedUni ...
Jul 28, 2023
0
36
A University of Queensland study has found skin with few visible freckles or blemishes may still carry sun-damaged DNA mutations that can trigger cancer. Researchers from UQ's Frazer Institute Dermatology Research Center ...
May 11, 2023
0
45
A one-year, placebo-controlled trial of oral nicotinamide (vitamin B3) therapy by the University of Sydney did not lead to lower rates of skin cancer in organ transplant recipients. The result is in striking contrast to a ...
